LINC01194

Across TCGA pan-cancer cohorts, LINC01194 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC01194 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC01194 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01194 expression acts as an unfavorable survival marker, although some lineages such as UCS and ACC show a favorable association.

KIRP, KIRC, and UVM are the cancer types where LINC01194 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	III,IV	0.209	0.750	<.001	102	view →
KIRC	OS	Tertile	All	0.533	0.662	.001	94	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	54	view →
READ	OS	Tertile	III,IV	0.252	0.830	<.001	51	view →
PAAD	OS	Tertile	All	0.420	0.600	.040	30	view →
KICH	DFS	Tertile	All	0.162	0.862	.014	27	view →
LIHC	DFS	Quartile	All	0.310	0.453	.002	24	view →
UCEC	OS	Tertile	All	0.886	0.937	.011	22	view →
COAD	DFS	Tertile	All	0.165	0.574	.019	21	view →
THCA	DFS	Tertile	IV	0.126	0.805	.002	18	view →
SARC	OS	Tertile	All	0.748	0.857	.010	18	view →
CHOL	DFS	Tertile	All	0.093	0.434	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC01194–KIRP (DFS)

Open the KIRP breakdown →